< Back to search
Filter
1

Patient Decision Aid in Supporting Decision-Making About When to Start or Stop New Drugs, Join Clinical Trials, or Continue Active Surveillance in Patients With Medullary Thyroid Cancer and Their Caregivers

for
Thyroid Gland Medullary Carcinoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT03892993

Recruiting

Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors

for
Melanoma, Medullary Thyroid Cancer,
Location: Tucson AZ, Seattle WA
Sponsor: University of Arizona

Sex: All

Age: 18 - 70+

Code: NCT06814496

Phase1, Phase2, Recruiting

A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours)

for
Advanced Relapsed or Refractory Germ Cell Tumours,
Location: Houston TX, Los Angeles CA
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT07306559

Phase1, Recruiting

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

for
Endometrial Cancer, Gastric Cancer,
Location: Commack NY, East Brunswick NJ, Columbus OH,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT05489211

Phase2, Recruiting

Phase 1 Safety Study of ACT-PFK-158, 2HCl in Patients With Advanced Solid Malignancies

for
Cancer
Location: Washington DC, Louisville KY, Houston TX,
Sponsor: Advanced Cancer Therapeutics

Sex: All

Age: 18+

Code: NCT02044861

Phase1, Recruiting

Interested in new solid tumor trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Featured

A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab Adizutecan

for
Solid Tumors Harboring MET Amplification
Location: New Haven CT, New York NY, Fairfax VA, Durham NC,
Sponsor: AbbVie

Sex: All

Age: 12+

Code: NCT07196644

Phase2, Recruiting
Featured

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

for
Non-Small Cell Lung Cancer,
Location: Montreal, Fairfax VA, Durham NC, Toronto,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT05005403

Phase1, Recruiting
Active & Responsive

A Study of YL201 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Boston MA, New York NY, Washington D.C. DC, Fairfax VA,
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.

Sex: All

Age: 18+

Code: NCT05434234

Phase1, Phase2, Recruiting

PEN-866 in Patients With Advanced Solid Malignancies

for
Carcinoma, Endometrial Adenocarcinoma, Neoplasms,
Location: Philadelphia PA, Bethesda MD, Fairfax VA,
Sponsor: Tarveda Therapeutics

Sex: All

Age: 18+

Code: NCT03221400

Phase1, Phase2, Recruiting

Dabrafenib and/or Trametinib Rollover Study

for
Melanoma, Non Small Cell Lung Cancer, Solid Tumor, Rare Cancers,
Location: Toronto
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT03340506

Recruiting

Phase 1 Study of ACR-2316 in Specific Advanced Solid Tumors

for
Specific Advanced Solid Tumors
Location: Boston MA, Providence RI, The Bronx NY, Fairfax VA,
Sponsor: Acrivon Therapeutics

Sex: All

Age: 18+

Code: NCT06667141

Phase1, Recruiting

A Study of MGC028 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors, NSCLC Adenocarcinoma, Cholangiocarcinoma,
Location: Boston MA, New York NY, Grand Rapids MI, San Antonio TX,
Sponsor: MacroGenics

Sex: All

Age: 18+

Code: NCT06723236

Phase1, Recruiting

A Phase I/II, Open-label Study to Investigate the Safety, Tolerability, PK, and Preliminary Efficacy of FB849

for
Advanced Solid Tumor
Location: Fairfax VA, Cleveland OH, Dallas TX, San Antonio TX,
Sponsor: 1ST Biotherapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05761223

Phase1, Phase2, Recruiting

A Study to Investigate ANS014004 in Participants With Locally Advanced or Metastatic Solid Tumors

for
Locally Advanced or Metastatic Solid Tumors
Location: New York NY, Fairfax VA, Toronto, Orlando FL,
Sponsor: Avistone Biotechnology Co., Ltd.

Sex: All

Age: 18+

Code: NCT06307795

Phase1, Recruiting

Promoting Physical Activity In After-School Programs for Urban Adolescents

for
Unspecified Adult Solid Tumor, Protocol Specific
Location: Montclair NJ
Sponsor: Montclair State University

Sex: All

Age: 11 - 14

Code: NCT00301158

Recruiting

Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants

for
Unspecified Adult Solid Tumor, Protocol Specific
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 18+

Code: NCT00992303

Recruiting

A DRF Study to Evaluate Safety, Tolerability, PK, and Activity of Oradoxel Monotherapy in Subjects w Adv. Malignancies

for
Solid Tumor
Location: Rochester MN, San Antonio TX, Phoenix AZ
Sponsor: Athenex, Inc.

Sex: All

Age: 18+

Code: NCT02963168

Phase1, Recruiting

Molecular Testing of Cancer by Integrated Genomic, Transcriptomic, and Proteomic Analysis

for
Solid Tumors, Hematological Malignancies
Location: Providence RI, East Greenwich RI
Sponsor: Rhode Island Hospital

Sex: All

Age: 18+

Code: NCT02213822

Recruiting

Regenecare® Wound Gel in Treating Rash in Patients Receiving Cetuximab or Other Epidermal Growth Factor Receptor Inhibitor Therapy for Cancer

for
Dermatologic Complications,
Location: Harvey IL
Sponsor: Ingalls Memorial Hospital

Sex: All

Age: 18+

Code: NCT00498992

Recruiting

A Study Evaluating MM-310 in Patients With Solid Tumors

for
Solid Tumors, Urothelial Carcinoma, Gastric Carcinoma,
Location: Durham NC, Buffalo NY, Rochester MN, Scottsdale AZ,
Sponsor: Merrimack Pharmaceuticals

Sex: All

Age: 18+

Code: NCT03076372

Phase1, Recruiting